Our Drug Transporter Sciences team at Cyprotex are delighted to announce publication of a review article in […]
Read more...Our Drug Transporter Sciences team at Cyprotex are delighted to announce publication of a review article in […]
Read more...Evaluating drug-drug interactions (DDI) of investigational drugs is an important part of the regulatory drug development process. […]
Read more...It can be challenging to navigate the requirements for drug interaction studies when each regulatory authority has […]
Read more...On 15th September 2021, the European parliament adopted a resolution vote to actively phase out the use […]
Read more...In January 2020, the US FDA gave its stamp of approval by finalising its 2017 draft regulatory […]
Read more...